Effects of drug, biobehavioral and exercise therapies on heart rate variability in coronary artery disease: A systematic review

European Journal of Preventive Cardiology

Volumn 15, Issue 4, 2008, Pages 386-396

  Nolan, Robert P ^a   Jong, Philip ^a   Barry Bianchi, Susan M ^a   Tanaka, Tim H ^b   Floras, John S ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TSUKUBA UNIVERSITY OF TECHNOLOGY   (Japan)

Author keywords

coronary artery disease; heart rate variability; meta analysis; secondary prevention

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROPRANOLOL; PSYCHOTROPIC AGENT; CARDIOVASCULAR AGENT;

ANXIETY; AUTONOMIC NERVOUS SYSTEM; BEHAVIOR THERAPY; CLINICAL TRIAL; COCHRANE LIBRARY; CORONARY ARTERY DISEASE; DEPRESSION; EMBASE; EXERCISE; FEEDBACK SYSTEM; HEART INFARCTION; HEART RATE VARIABILITY; HOSTILITY; HUMAN; KINESIOTHERAPY; LANGUAGE; MEDITATION; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; PARASYMPATHETIC TONE; PRIORITY JOURNAL; PROGNOSIS; PSYCINFO; RELAXATION TRAINING; REVIEW; SECONDARY PREVENTION; SENSITIVITY ANALYSIS; STANDARDIZATION; STRESS; SYMPATHETIC TONE; SYSTEMATIC REVIEW; VAGUS NERVE STIMULATION; YOGA; HEART RATE; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

BEHAVIOR THERAPY; CARDIOVASCULAR AGENTS; CORONARY ARTERY DISEASE; EXERCISE THERAPY; HEART RATE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 55249104128     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e3283030a97     Document Type: Review

References (46)

1. Buxton AE, Calkins H, Callans DJ, DiMarco JP, Fisher JD, Greene HL, et al ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology). Circulation 2006; 114: 2534–2570.
2. Kleiger RE, Stein PK, Bigger JT Jr. Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol 2005; 10: 88–101.
3. Bailey JJ, Berson AS, Handelsman H, Hodges M. Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction. J Am Coll Cardiol 2001; 38: 1902–1911.
4. Lampert R, Ickovics JR, Viscoli CJ, Horwitz RI, Lee FA. Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-blocker Heart Attack Trial. Am J Cardiol 2003; 91: 137–142.
5. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 1999; 354: 1896–1900.
6. Task Force of the European Society of Cardiology and the North American Society of Pacing Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996; 93: 1043–1065.
7. Manfrini O, Pizzi C, Viecca M, Bugiardini R. Abnormalities of cardiac autonomic nervous activity correlate with expansive coronary artery remodeling. Atherosclerosis 2008; 197: 183–189.
8. Pyetan E, Toledo E, Zoran O, Akselrod S. Parametric description of cardiac vagal control. Auton Neurosci 2003; 109: 42–52.
9. Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care. Can Med Assoc J 2003; 169: 207–208.
10. Bonaduce D, Petretta M, lanniciello A, Apicella C, Cavallaro V, Marciano F. Comparison of verapamil versus felodipine on heart rate variability after acute myocardial infarction. Am J Cardiol 1997; 79: 564–569.
11. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT Jr, et al Sertraline treatment of major depression in patients with acute Ml or unstable angina. J Am Med Assoc 2002; 288: 701–709.
12. La Rovere MT, Mortara A, Sandrone G, Lombardi F. Autonomic nervous system adaptations to short-term exercise training. Chest 1992; 101: 299S–303S.
13. Rossinen J, Partanen J, Nieminen MS. Amlodipine in patients with stable angina pectoris treated with beta-blockers. Double-blind comparison with placebo. Scand Cardiovasc J 1998; 32: 41–48.
14. Sanderson JE, Yeung LY, Chan S, Tomlinson B, Kay R, Woo KS, et al Effect of beta-blockade on baroreceptor and autonomic function in heart failure. Clin Sci (Lond) 1999; 96: 137–146.
15. Vaage-Nilsen M, Rasmussen V. Effect of verapamil on heart rate variability after an acute myocardial infarction. Danish Verapamil Infarction Trial II. Cardiovasc Drugs Ther 1998; 12: 285–290.
16. Hedges LV. Estimation of effect size from a series of independent experiments. Psychol Bull 1982; 92: 490–499.
17. Kalaian HA, Raudenbush SW. A multivariate mixed linear model for metaanalysis. Psychol Met 1996; 1: 227–235.
18. Cohen J. Statistical power analysis for the behavioral sciences. New York: Academic Press; 1969.
19. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (autonomic tone and reflexes after myocardial infarction) Investigators. Lancet 1998; 351: 478–484.
20. Niemela MJ, Airaksinen KE, Huikuri HV. Effect of beta-blockade on heart rate variability in patients with coronary artery disease. J Am Coll Cardiol 1994; 23: 1370–1377.
21. Zhang YH, Song YC, Zhu J, Hu TH, Wan LL. Effects of enalapril on heart rate variability in patients with congestive heart failure. Am J Cardiol 1995; 76: 1045–1048.
22. Kontopoulos AG, Athyros VG, Papageorgiou AA, Papadopoulos GV, Avramidis MJ, Boudoulas H. Effect of quinapril or metoprolol on heart rate variability in postmyocardial infarction patients. Am J Cardiol 1996; 77: 242–246.
23. Takase B, Hikita H, Uehata A, Satomura K, Kurita A, Nakamura H. Effect of carteolol on silent myocardial ischemia, variability in heart rate, and the pain-modulating system. Am Heart J 1997; 134: 945–954.
24. Acanfora D, Pinna GD, Gheorghiade M, Trojano L, Furgi G, Maestri R, et al Effect of beta-blockade on the premature ventricular beats/heart rate relation and heart rate variability in patients with coronary heart disease and severe ventricular arrhythmias. Am J Ther 2000; 7: 229–236.
25. Tjeerdsma G, Szabo BM, van Wijk LM, Brouwer J, Tio RA, Crijns HJ, et al Autonomic dysfunction in patients with mild heart failure and coronary artery disease and the effects of add-on beta-blockade. Eur J Heart Fail 2001; 3: 33–39.
26. McFarlane A, Kamath MV, Fallen EL, Malcolm V, Cherian F, Norman G. Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction. Am Heart J 2001; 142: 617–623.
27. Nolan RP, Kamath MV, Floras JS, Stanley J, Pang C, Picton P, et al Heart rate variability biofeedback as a behavioral neurocardiac intervention to enhance vagal heart rate control. Am Heart J 2005; 149: 1137.
28. van Dixhoorn J. Cardiorespiratory effects of breathing and relaxation instruction in myocardial infarction patients. Biol Psychol 1998; 49: 123–135.
29. Del Pozo JM, Gevirtz RN, Scher B, Guarneri E. Biofeedback treatment increases heart rate variability in patients with known coronary artery disease. Am Heart J 2004; 147: E11.
30. Blumenthal JA, Sherwood A, Babyak MA, Watkins LL, Waugh R, Georgiades A, et al Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease: a randomized controlled trial. J Am Med Assoc 2005; 293: 1626–1634.
31. Paul-Labrador M, Polk D, Dwyer JH, Velasquez I, Nidich S, Rainforth M, et al Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease. Arch Intern Med 2006; 166: 1218–1224.
32. Duru F, Candinas R, Dziekan G, Goebbels U, Myers J, Dubach P. Effect of exercise training on heart rate variability in patients with new-onset left ventricular dysfunction after myocardial infarction. Am Heart J 2000; 140: 157–161.
33. Piepoli M, Group EHFT. Experience from controlled trials of physical training in chronic heart failure. Protocol and patient factors in effectiveness in the improvement in exercise tolerance. European Heart Failure Training Group. Eur Heart J 1998; 19: 466–475.
34. Iellamo F. Neural mechanisms of cardiovascular regulation during exercise. Auton Neurosci 2001; 90: 66–75.
35. Leitch JW, Newling RP, Basta M, Inder K, Dear K, Fletcher PJ. Randomized trial of a hospital-based exercise training program after acute myocardial infarction: cardiac autonomic effects. J Am Coll Cardiol 1997; 29: 1263–1268.
36. Stahle A, Nordlander R, Bergfeldt L. Aerobic group training improves exercise capacity and heart rate variability in elderly patients with a recent coronary event. A randomized controlled study. Eur Heart J 1999; 20: 1638–1646.
37. Takeyama J, Itoh H, Kato M, Koike A, Aoki K, Fu LT, et al Effects of physical training on the recovery of the autonomic nervous activity during exercise after coronary artery bypass grafting: effects of physical training after CABG. Jpn Circ J 2000; 64: 809–813.
38. Mazzuero G, Lanfranchi P, Colombo R, Giannuzzi P, Giordano A. Long-term adaptation of 24-h heart rate variability after myocardial infarction. The EAMI Study Group. Exercise training in anterior myocardial infarction. Chest 1992; 101: 304S–308S.
39. Oya M, Itoh H, Kato K, Tanabe K, Murayama M. Effects of exercise training on the recovery of the autonomic nervous system and exercise capacity after acute myocardial infarction. Jpn Circ J 1999; 63: 843–848.
40. Adamopoulos S, Ponikowski P, Cerquetani E, Piepoli M, Rosano G, Sleight P, et al Circadian pattern of heart rate variability in chronic heart failure patients. Effects of physical training. Eur Heart J 1995; 16: 1380–1386.
41. Coats AJ, Adamopoulos S, Radaelli A, McCance A, Meyer TE, Bernardi L, et al Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function. Circulation 1992; 85: 2119–2131.
42. Adamopoulos S, Piepoli M, McCance A, Bernardi L, Rocadaelli A, Ormerod O, et al Comparison of different methods for assessing sympathovagal balance in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1992; 70: 1576–1582.
43. Selig SE, Carey MF, Menzies DG, Patterson J, Geerling RH, Williams AD, et al Moderate-intensity resistance exercise training in patients with chronic heart failure improves strength, endurance, heart rate variability, and forearm blood flow. J Card Fail 2004; 10: 21–30.
44. Carunchio A, Fera MS, Bordi L, Daniele R, Rulli F, Coletta C, et al The effect of cardiovascular rehabilitation on the variability of the RR cycle after a first uncomplicated acute myocardial infarct. Ital Heart J Suppl 2000; 1: 241–249.
45. Tsai MW, Chie WC, Kuo TB, Chen MF, Liu JP, Chen TT, et al Effects of exercise training on heart rate variability after coronary angioplasty. Phys Ther 2006; 86: 626–635.
46. Taylor RS, Unal B, Critchley JA, Capewell S. Mortality reductions in patients receiving exercise-based cardiac rehabilitation: how much can be attributed to cardiovascular risk factor improvements? Eur J Cardiovasc Prev Rehabil 2006; 13: 369–374.